title: Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells.
abstract: Atherosclerosis is a complex vascular inflammatory disease. Oxidized low-density lipoprotein (ox-LDL) is directly associated with chronic vascular inflammation. In this study, we hypothesized that nonselective cyclooxygenase inhibitor aspirin might affect the ox-LDL-induced inflammatory responses on human endothelial cells. To test this assumption, cyclooxygenase-2 (COX-2) and intercellular adhesion molecule-1 (ICAM-1) expression, IkappaB and p38 mitogen-activated protein kinase (MAPK) phosphorylation were determined in endothelial cells exposed to ox-LDL in the presence of aspirin. The results showed that aspirin significantly suppressed COX-2 and ICAM-1 expression induced by ox-LDL and also inhibited IkappaB phosphorylation in human umbilical vein endothelial cells (HUVECs). Moreover, aspirin reduced the level of p38 MAPK phosphorylation. Our findings suggest that aspirin can decrease inflammatory responses induced by ox-LDL, and the mechanism might be associated with NF-kappaB activation pathway and inhibition of p38 MAPK phosphorylation.
authors.affiliation: Anzhen Hospital, Capital Medical University, Beijing, China.
authors.forename: Jinjing
authors.initials: J
authors.lastname: Zhao
authors.forename: Ruomei
authors.initials: R
authors.lastname: Qi
authors.forename: Rui
authors.initials: R
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Wu
authors.forename: Xin
authors.initials: X
authors.lastname: Gao
authors.forename: Li
authors.initials: L
authors.lastname: Bao
authors.forename: Shuzheng
authors.initials: S
authors.lastname: Lu
mesh_terms: D001241:Aspirin / Q000494:pharmacology*; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000187:drug effects / Q000378:metabolism; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000187:drug effects / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000494:pharmacology*; D016328:NF-kappa B / Q000187:drug effects / Q000378:metabolism; D010766:Phosphorylation; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D014471:Umbilical Veins; D048051:p38 Mitogen-Activated Protein Kinases / Q000187:drug effects / Q000378:metabolism
chemical_list: D008077:Lipoproteins, LDL; D016328:NF-kappa B; D010975:Platelet Aggregation Inhibitors; C099252:oxidized low density lipoprotein; D018799:Intercellular Adhesion Molecule-1; D051546:Cyclooxygenase 2; D048051:p38 Mitogen-Activated Protein Kinases; D001241:Aspirin